Health
Nanoparticle based shot could boost efficacy, accelerate production of seasonal flu vaccines – BioPharma-Reporter.com
Seasonal flu vaccines typically work 40-60% of the time, according to the US Centers for Disease Control and Prevention (CDC). An experimental recombinant protein…
Key to the vaccine’s success is a liposome the developers created called cobalt-porphyrin-phospholipid, or CoPoP. They are tiny spherical sacs, which are small enough to be considered nanoparticles, and they form the backbone of the vaccine platform.
Described in a study published on May 24 by the Proceedings of the National Academy of Science, the experimental vaccine has reportedly proven effective in preclinical studies.
The results are very encouraging, says the study’s senior author, Jonathan…
-
Noosa News20 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News23 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards
-
Noosa News21 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News23 hours agoHelicopter scrambles to site of air crash on K’gari